Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Rubella

Rubella, commonly known as German measles, is a disease caused by Rubella virus. The name is derived form the Latin, meaning little red. Rubella is also known as German measles because the disease was first described by German physicians in the mid-eighteenth century. This disease is often mild and attacks often pass unnoticed. The disease can last one to five days. Children recover more quickly than adults. Infection of the mother by Rubella virus during pregnancy can be serious; if the mother is infected within the first 20 weeks of pregnancy, the child may be born with congenital rubella syndrome , which is a range of serious incurable illnesses. Spontaneous abortion occurs in up to 20% of cases. Rubella is a common childhood infection usually with minimal systemic upset although transient arthropathy may occur in adults. Serious complications, which include allergic encephalomyelitis and SSPE, are very rare. If it were not for the effects of transplacental infection on the developing foetus, rubella is a relatively trivial infection.Acquired, , rubella is transmitted via airborne droplet emission from the upper respiratory tract of active cases. The virus may also be present in the urine, faeces and on the skin. There is no carrier state: the reservoir exists entirely in active human cases. The disease has an incubation period of 2 to 3 weeks.In most people the virus is rapidly eliminated however, it may persist for some months post partum in infants surviving the CRS. These children were an important source of infection to other infants and, more importantly pregnant female contacts (From the Wikpedia article Rubella.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Rubella:

Pubmed Logo
Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes.
In Sweden, more than 30 years after the introduction of vaccination for...
21st November, 2009
Department of Virology, Swedish Institute for Infectious Disease Control, Vaccine. 2009 Nov 16.
DOI Direct Link
[Clinical and pathological features of adult patients with acquired rubella]
OBJECTIVE: To explore the clinical and pathological features of liver...
17th November, 2009
Department of Infectious Diseases, the 456th Hospital of PLA, Jinan Zhonghua Gan Zang Bing Za Zhi. 2009 Jul;17(7):540-3.
Congenital rubella pneumonitis complicated by Pneumocystis jiroveci infection with positive long term respiratory outcome: A case report and literature review.
Rubella remains to be a significant illness in the developing countries...
17th November, 2009
Queensland Respiratory Centre, Royal Children's Hospital, Herston, Pediatr Pulmonol. 2009 Nov 12;44(12):1235-1239.
DOI Direct Link
Congenital rubella syndrome: pattern and presentation in a southern Nigerian tertiary hospital.
BACKGROUND: Congenital rubella syndrome (CRS) resulting from maternal...
17th November, 2009
Department of Pediatrics and Child Health, University of Port Harcourt World J Pediatr. 2009 Nov;5(4):287-91. Epub 2009 Nov 13.
DOI Direct Link
Confocal Scan Features of Keratic Precipitates in Fuchs Heterochromic Iridocyclitis.
PURPOSE:: To characterize confocal scan features of keratic precipitates...
13th November, 2009
From the *Ophthalmology Department and Ophthalmic Research Center, Cornea. 2009 Nov 14.
DOI Direct Link

View more research publications.

Press Releases About Rubella:

BioPortfolio Logo
Hard to Treat Diseases' (HTDS) MMR Vaccine Passed the Chinese SFDA's 'First Drug Evaluation' 16th November, 2009 Hard to Treat Diseases
SHENZHEN, China, Nov. 16 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) and its China subsidiary Mellow Hope announce that its MMR vaccine (Measles, Mumps and
CDC's Advisory Committee on Immunization Practices Meeting 17th June, 2009 Centers for Disease Control and Prevention
Please Note the Need to RSVP What: Meeting of the Advisory Committee on Immunization Practices (ACIP). When: Wednesday through Friday, June 24-26, 2009 Where: Centers for Disease Control and
National 'Cherokee Inspired Comfort Award' Winners Announced 13th October, 2008 Cherokee Uniforms
LOS ANGELES, Oct. 13 /PRNewswire/ -- Cherokee Uniforms announced today 10 winners of the 2008 Cherokee Inspired Comfort Award. The recipients represent a cross-section of healthcare facilities,
An Innovation in Health Care Opens Inside CVS/Pharmacy Stores in Columbia and Greenville Markets 10th September, 2008 MinuteClinic
COLUMBIA, S.C., Sept. 10 /PRNewswire/ -- MinuteClinic (http://www.minuteclinic.com), the pioneer and largest provider of retail- based health care in the United States, today opened its first
Destroy Back-to-School Cold and Flu Woes With Duraban's Antibacterial, Antimicrobial Barrier Solution 7th August, 2008 BDA Industries, LLC
WEST PALM BEACH, Fla., Aug. 7 /PRNewswire/ -- According to the U.S. Centers for Disease Control and Prevention (CDC), the common cold is one of the most common causes of absenteeism at work and

BioNews Results for Rubella:

RSS Logo
BioPortfolio Logo
HTDS' MMR vaccine passes SFDA's First Drug Evaluation
Bio Spectrum Asia:  Nov 19 2009 8:02AM Matching: rubella
Hard to Treat Diseases' (HTDS) MMR Vaccine Passed the Chinese SFDA's 'First Drug Evaluation'
Individual.com:  Nov 17 2009 9:52AM Matching: rubella
Hard to Treat Diseases' (HTDS) MMR Vaccine Passed the Chinese SFDA's 'First Drug Evaluation'
Birmingham Business Journal:  Nov 16 2009 8:55PM Matching: rubella
Hard to Treat Diseases' (HTDS) MMR Vaccine Passed the Chinese SFDA's 'First Drug Evaluation'
Business Journal of Tampa Bay:  Nov 16 2009 8:55PM Matching: rubella
Hard to Treat Diseases' (HTDS) MMR Vaccine Passed the Chinese SFDA's 'First Drug Evaluation'
Reuters:  Nov 16 2009 8:49PM Matching: rubella
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Rubella Patents:

USPTO Logo
US Patent No.Title
7597936 Method of producing a pigmented composite microporous material
7601870 Substituted aniline derivatives
7601872 Transfection reagents
7604801 Methods for detecting parvovirus infections
7604802 Method of obtaining cellular immune responses from proteins

View more patents.

Companies working in the area of Rubella from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

TOMTEC

Tomtec has succeeded since 1967 by working with its clients to help solve their liquid handling needs. From 1967 to 1981, the Company had essentially one employee, Tom Astle. From 1967 to 1971, the...
www.tomtec.com/        View full profile
Thumbshot

Viral Antigens, Inc

VIRAL ANTIGENS, INC. was founded in September of 1982 to commercialize techniques for producing high quality antigens and viral components and attaching them to latex beads. Research on rubella virus...
www.viralantigens.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Rubella scientists - we have details of around 1144 individuals working on Rubella .


This page has been viewed 492 times
Recent Search Terms used to find this page: rubella today in 2009 | BDA INDUSTRIES | rubella research | rubella adults vienna | how is rubella transmitted | rubella research | is rubella hard to treat | journal of rubella 2009 | rubella research | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Rubella across BioPortfolio, or for Rubella Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.